Seven senators are questioning why Sanofi and AstraZeneca underestimated the demand for Beyfortus, the first pediatric drug approved for respiratory syncytial virus.
Read the full post on Becker's Hospital Review - Healthcare News
Senators prod Beyfortus drugmaker over shortage
